Vyndamax
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Vyndamax, covering 2013-05-21 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy